Premature ventricular contractions (PVCs) are early depolarizations of the myocardium originating in the ventricle.
INTRODUCTION
Premature ventricular contractions (PVCs) are early depolarizations of the myocardium originating in the ventricle (Fig. 1 ). PVCs are common with an estimated prevalence of 1% to 4% in the general population on standard 12-lead electrocardiography and between 40% and 75% of subjects on 24-to 48-hour Holter monitoring [1, 2] . Ventricular ectopic activity occurs in a wide variety of clinical settings with a spectrum of clinical implications. They are often seen in association with structural heart disease and represent increased risk of sudden death, yet they are ubiquitous, even in the absence of identifiable heart disease [3, 4] . Traditionally, they have been thought to be relatively benign in the absence of structural heart disease [2, 5] . Over the last decade, however, PVC-induced cardiomyopathy (CMP) has been a subject of great interest and the evidence for this entity is rapidly emerging. Appropriate clinical evaluation and investigations are important in assessing patients with PVCs so that effective treatment can be targeted when necessary. This article discusses the current knowledge and practice in this commonly encountered clinical cardiological problem. [9] . pected heart disease. PVCs and runs of NSVT in subjects with structural heart disease contribute to an increased mortality risk, the magnitude of which varies with the nature and extent of the underlying disease. LVEF below 40% [6, 7] . In a multicenter postmyocardial infarction study, 766 patients with acute myocardial infarction had their LVEFs measured by radionuclide methods and a 24 hr ECG analyzed by sensitive and specific methods. Out of these 766 patients, 86 deaths occurred during the 3 year follow-up period. When the variables were analyzed separately, there were strong associations between death and LVEF, frequency of VPCs, or repetitiveness of VPCs [8] . In the GISSI trial, Twenty-four-hour Holter recordings obtained before discharge from the hospital in [11] . ICD therapy is indicated in patients with NSVT due to prior myocardial infarction, LVEF less than or equal to 40%, and inducible ventricular fibrillation or sustained VT at electrophysiological study [12] .
Heart failure
Although we might expect all patients with LV dysfunction to die from progressive heart failure, many die suddenly and unexpectedly without any evidence of recent hemodynamic or functional deterioration. Sudden death is the final event in approximately 35-50% of patients with chronic heart failure [13] . The patient with chronic heart failure is not only at risk of sudden death but is also likely to manifest serious ventricular arrhythmias. In addition to their hemodynamic derangements, patients with chronic heart failure have numerous electrical abnormalities that develop and progress in parallel with the mechanical dysfunction. The prevalence and complexity of ambulatory ventricular arrhythmias increase dramatically as LV function deteriorates [14] . In patients with a LVEF of less than 40%, the prevalence of NSVT rises from 15-20% in patients with class I-II symptoms of heart failure to 40-55% in class II-III patients and 50-70% in class III-IV patients [15] . Numerous studies have shown an independent direct relationship of complex cardiac arrhythmias (repetitive forms) and LV dysfunction with subsequent mortality [16] [17] [18] . But in the CHF STAT study, NSVT was frequently seen in patients with heart failure and was associated with worsened survival by univariate analysis. However, after adjusting other variables, especially for EF, NSVT was not an independent predictor of all-cause mortality or sudden death. The suppression of NSVT by amiodarone had no effect on total survival nor on sudden cardiac death [19] . The Prospective Randomized Milrinone Survival Evaluation (PROMISE) study was undertaken to determine whether ventricular arrhythmias were independent and specific predictors of sudden death. In this study, ventricular arrhythmias did not specifically define a group at high risk for sudden death and did not provide significant incremental prognostic information beyond readily available clinical variables (Fig. 3) [20] . The presence of complex ventricular arrhythmias (especially NSVT) on ambulatory monitoring predicts total cardiac mortality but does not identify patients who are destined to die suddenly. This observation suggests that the frequency and complexity of rhythm disturbances in patients with severe heart failure reflect the severity of the underlying disease process rather than a specific arrhythmogenic state. NSVT should not guide therapeutic interventions, such as the institution of antiarrhythmic therapy or implantation of antifibrillatory devices.
Premature ventricular complexes in the absence of heart disease
In the Tecumseh, Michigan, communitywide cardiovascular epidemiology study, PVCs in subjects with structur- ally normal hearts carried no adverse prognostic significance under the age of 30 years, but in those older than 30 years, PVCs and short runs of NSVT began to influence risk [21] .
More recent studies provide conflicting implications regarding risk in asymptomatic subjects. In one study [22] , asymptomatic ventricular arrhythmias in the absence of identifiable heart disease predicted a small increase in risk, while another study [23] 
PREMATURE VENTRICULAR CONTRACTION-INDUCED CARDIOMYOPATHY
Traditionally, PVCs have been thought to be relatively benign in the absence of structural heart disease [2, 5] . Over the last decade, however, PVC-induced CMP has been a subject of great interest and the evidence for this entity is with depressed ventricular function [28] . ＞24% had a sensitivity and specificity of 79% and 78%, respectively, in separating the patient populations with impaired versus preserved LV function [34] . But in another study, the threshold burden of PVCs for reduced LVEF differed between those with a LV and those with a RV site of origin of PVCs. PVCs originating from the RV were associated with a significantly increased prevalence of reduced LVEF at a PVC burden ≥10%, whereas PVCs originating from the LV were associated with reduced LVEF only at a PVC burden ≥20% [35] . In the MOST trial, ventricular pacing in the DDDR mode ＞40% of the time conferred a 2.6-fold increased risk of heart failure hospitalization compared with less pacing. This provided some evidence that highly paced patients are not only at greater risk for heart failure hospitalization but are also hospitalized for heart failure more often [36] . Even though the burden of PVCs seems to be an important determinant of LV systolic dysfunction, some patients with a high PVC burden do not develop CMP. This suggests that in addition to the PVC burden, other characteristics of PVCs might also be contributory [37] . at a lower threshold PVC burden than that for LV PVCs as described above [35] . In some recent studies, longer PVC QRS duration was also associated with the presence of CMP.
Risk factors for PVCs induced cardiomyopathy
However, in a subgroup of patients with very wide PVCs (mean QRS duration 173 ms), successful suppression of PVCs failed to normalize LV function [38, 39] .
Mechanism of PVC induced cardiomyopathy
The mechanism of PVC-CMP is presumed to be related to PVC-induced LV dyssynchrony. Indeed, every known mechanism of LV dyssynchrony (left bundle branch block, right ventricular pacing, and preexcitation) can produce CMP [40, 41] . Although QRS duration is a major determinant of LV dyssynchrony, significant variation in LV activation patterns and degree of dyssynchrony exists between various wide QRS morphologies [42] . To predict the future development of PVC-CMP, methods of direct LV dyssynchrony assessment during PVC might be required. Additional factors such as dyssynchrony-induced papillary muscle dysfunction that can cause mitral regurgitation with additional LV volume overload, and autonomic response modification by variations in ventriculoatrial conduction, can affect CMP development and have not been studied systematically [43, 44] .
TREATMENT OF PVCs
When considering the need for further intervention and planning treatment for patients with VPCs, it is important to consider: (1) whether there is underlying heart disease; 
